Literature DB >> 10470675

Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.

F Nara1, M Tanaka, T Hosoya, K Suzuki-Konagai, T Ogita.   

Abstract

We performed experiments to screen for neutral sphingomyelinase inhibitors using rat brain microsomes as an enzyme source. Among more than 10,000 microbial extracts tested, a mycelial extract of Trichopeziza mollissima SANK 13892 exhibited potent inhibitory activity. The active compound, scyphostatin, was purified by a series of chromatographies. Scyphostatin inhibited the enzyme with an IC50 value of 1.0 microM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470675     DOI: 10.7164/antibiotics.52.525

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  14 in total

Review 1.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 2.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Highly(≥98%) Stereo- and Regioselective Trisubstituted Alkene Synthesis of Wide Applicability via 1-Halo-1-alkyne Hydroboration-Tandem Negishi-Suzuki Coupling or Organoborate Migratory Insertion Protocol.

Authors:  Shiqing Xu; Ching-Tien Lee; Honghua Rao; Ei-Ichi Negishi
Journal:  Adv Synth Catal       Date:  2011-11       Impact factor: 5.837

4.  Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis.

Authors:  J K Chen; J Capdevila; R C Harris
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 5.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

6.  Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum.

Authors:  K Hanada; T Mitamura; M Fukasawa; P A Magistrado; T Horii; M Nishijima
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 7.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

8.  Dynamic kinetic resolution during a vinylogous Payne rearrangement: a concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin.

Authors:  Thomas R Hoye; Christopher S Jeffrey; Dorian P Nelson
Journal:  Org Lett       Date:  2010-01-01       Impact factor: 6.005

Review 9.  Role of phospholipid synthesis in the development and differentiation of malaria parasites in the blood.

Authors:  Nicole Kilian; Jae-Yeon Choi; Dennis R Voelker; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2018-10-04       Impact factor: 5.157

Review 10.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.